Related Experiment Video
Updated: Aug 4, 2026
Simultaneous Assessment of Cardiomyocyte DNA Synthesis and Ploidy: A Method to Assist Quantification of Cardiomyocyte Regeneration and Turnover
Published on: May 23, 2016
Usefulness of DNA quantification in diagnosis of hypertrophic cardiomyopathies A preliminary study
F Martínez Díaz1, M Bernal Gilar, A Ruiz Saurí
1Department of Pathology, Medicine School, University of Murcia, Spain.
Insights
Hypertrophic cardiomyopathies (HCM) show distinct DNA index patterns. This DNA analysis aids in differentiating between essential, hypertensive, and toxic HCM types, improving diagnosis.
Area of Science:
- Cardiovascular Pathology
- Molecular Cardiology
- Biomolecular Analysis
Background:
- Hypertrophic cardiomyopathies (HCM) are a significant cause of sudden cardiac death.
- Alterations in cardiomyocyte DNA quantity are implicated in HCM pathogenesis.
- Morphological differences exist, but DNA content may offer crucial insights.
Purpose of the Study:
- To investigate the DNA index characteristics in various hypertrophic cardiomyopathies.
- To assess the utility of DNA index analysis in differentiating HCM subtypes.
- To correlate DNA index patterns with clinical and pathological features.
Main Methods:
- Analysis of DNA index in cardiomyocytes from 30 hypertrophic cardiomyopathy cases (10 essential, 10 hypertensive, 10 toxic).
- Comparison with DNA index from 10 macroscopically normal hearts.
- Statistical analysis correlating DNA index with age, heart weight, and ventricle thickness.
Main Results:
- Normal hearts exhibited a diploid DNA index.
- Hypertensive cardiomyopathies showed a tetraploid DNA index.
- Essential and toxic cardiomyopathies displayed aneuploid DNA indices (essential >2, toxic 1.1-1.9).
- Significant associations (p < 0.001) found between DNA values and HCM type, age, and cardiac dimensions.
Conclusions:
- DNA index analysis is statistically linked to hypertrophic cardiomyopathy etiology.
- This technique shows promise as a valuable tool for the differential diagnosis of HCM.
- Understanding DNA content variations can elucidate HCM pathogenesis and evolution.
Abstract:
Hypertrophic cardiomyopathies (HCM) are a frequent cause of sudden death in both young people and adults. Different cardiomyopathies can be distinguished according to the etiological agent and, although there are morphological differences too, alterations in the quantity of DNA in the cardiomyocytes may play an important role in their pathogenesis and evolution. To understand the characteristics and the behaviour of the DNA index in hypertrophic cardiomyopathies, we have studied thirty cases (10 primaries or essential, 10 hypertensives and 10 toxic) and compared the results with those obtained for 10 macroscopically normal hearts. The results showed that the different cardiomyopathies were statistically related with age, heart weight and ventricle thickness. The normal hearts showing a diploid DNA index, hypertensive cardiomyopathies (CM) hearts a tetraploid index and both toxic CM (1.1-1.9) and essential CM (>2) heart showing an aneuploid index. Statistically significant associations (p < 0.001) were observed when the DNA values were compared with the type of CM, the age, the thickness of both ventricles and the heart weight. Therefore, we think that the technique described may be of great help in the differential diagnosis of hypertrophic cardiomyopathies.
